Mirai (MIT breast cancer risk from mammograms)
Reads a mammogram to estimate five-year breast cancer risk, consistently across races and devices.
Science Translational Medicine 2021; validated across seven hospitals in several countries; used in risk-adapted screening trials.
How it works
Mirai applies deep learning to mammograms with device-conditional adversarial training.
- Cross-site consistency
- Prospective impact still under study
Latest papers
topQuery for this technology: (TITLE:"Mirai" OR ABSTRACT:"Mirai" OR TITLE:"MIT breast cancer risk from mammograms" OR ABSTRACT:"MIT breast cancer risk from mammograms") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Mirai (MIT breast cancer risk from mammograms), not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologySybil (MIT/MGH lung cancer risk from CT)
Shares AI in the oncology clinic: from narrow cleared tools to multimodal decision support, Massachusetts General Hospital Cancer Center, AI in radiology and the tags risk-model, radiology.
- PersonLeif W. Ellisen
Shares Massachusetts General Hospital Cancer Center, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- TechnologyAidoc CARE (clinical radiology foundation model)
Shares AI in radiology and the tag radiology.
- TechnologyRadFM (generalist radiology foundation model)
Shares AI in radiology and the tag radiology.
- IdeaSet each woman's mammogram interval from her last mammogram, using AI risk
Shares Mammography & tomosynthesis, AI in radiology, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- TechnologyMedSAM / SAM-Med3D (segment anything for medicine)
Shares AI in radiology and the tag radiology.
- TechnologyCT-FM (whole-body CT foundation model)
Shares AI in radiology and the tag radiology.
- PersonLaura J. Esserman
Shares Mammography & tomosynthesis, AI in radiology, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.